Send me a link:

*Text messaging rates may apply.

 Dow Down 0.19% Nasdaq Up 0.45%

More On BLRX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BioLineRx, Ltd. (BLRX)

-NCM
1.87 Down 0.04(2.09%) Jul 30, 3:59PM EDT
Prev Close:1.91
Open:1.94
Bid:1.85 x 200
Ask:2.27 x 1000
1y Target Est:7.33
Beta:3.06
Next Earnings Date:N/A
Day's Range:1.85 - 1.94
52wk Range:1.79 - 3.34
Volume:122,486
Avg Vol (3m):93,433
Market Cap:63.51M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.42
Quarterly EPS Est (Jun-14) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioLineRx Ltd., a clinical stage biopharmaceutical development company, is engaged in identifying, in-licensing, and developing therapeutic candidates that address unmet medical needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback